Quarterly report pursuant to Section 13 or 15(d)

Note 4 - Other Intangible Assets - Identifiable Intangible Assets Carrying Value (Details)

v3.5.0.2
Note 4 - Other Intangible Assets - Identifiable Intangible Assets Carrying Value (Details) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2016
Dec. 31, 2015
Diagnostic Test, Thyroid [Member] | Asuragen [Member]    
Finite-lived intangible asset, useful life 9 years  
Finite-Lived Intangible Assets, Net $ 8,519 $ 8,519
Diagnostic Test, Pancreas [Member] | Asuragen [Member]    
Finite-lived intangible asset, useful life  
Finite-Lived Intangible Assets, Net 2,882
Diagnostic Test, Pancreas [Member] | RedPath [Member]    
Finite-lived intangible asset, useful life 7 years  
Finite-Lived Intangible Assets, Net $ 16,141 16,141
Diagnostic Test, Biobank [Member] | Asuragen [Member]    
Finite-lived intangible asset, useful life  
Finite-Lived Intangible Assets, Net 1,575
Diagnostic Test, Barrett's RedPath [Member] | RedPath [Member]    
Finite-lived intangible asset, useful life 9 years  
Finite-Lived Intangible Assets, Net $ 18,351 18,351
CLIA Diagnostic Lab [Member]    
Finite-lived intangible asset, useful life 2 years 109 days  
Finite-Lived Intangible Assets, Net $ 609 609
RedPath [Member]    
Finite-Lived Intangible Assets, Net 43,011 47,468
Finite-Lived Intangible Assets, Net 37,220 43,492
Finite-Lived Intangible Assets, Accumulated Amortization $ (6,400) $ (4,585)